27 Sep Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Order Instructions

Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

 

Gastrointestinal (GI) and hepatobiliary disorders affect the structure and function of the GI tract. Many of these disorders often have similar symptoms, such as abdominal pain, cramping, constipation, nausea, bloating, and fatigue. Since multiple disorders can be tied to the same symptoms, it is important for advanced practice nurses to carefully evaluate patients and prescribe a treatment that targets the cause rather than the symptom.

 

Once the underlying cause is identified, an appropriate drug therapy plan can be recommended based on medical history and individual patient factors. In this Assignment, you examine a case study of a patient who presents with symptoms of a possible GI/hepatobiliary disorder, and you design an appropriate drug therapy plan.

 

To Prepare

Review the case study assigned by your Instructor for this Assignment

Reflect on the patient’s symptoms, medical history, and drugs currently prescribed.

Think about a possible diagnosis for the patient. Consider whether the patient has a disorder related to the gastrointestinal and hepatobiliary system or whether the symptoms are the result of a disorder from another system or other factors, such as pregnancy, drugs, or a psychological disorder.

Consider an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.

By Day 7 of Week 4

Write a 1-page paper that addresses the following:

 

Explain your diagnosis for the patient, including your rationale for the diagnosis.

Describe an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.

Justify why you would recommend this drug therapy plan for this patient. Be specific and provide examples.

Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at http://writingcenter.waldenu.edu/57.htm). All papers submitted must use this formatting.

 

CASE STUDY:

Week 4 Assignment

DC is a 46-year-old female who presents with a 24-hour history of RUQ pain. She states the pain started about 1 hour after a large dinner she had with her family. She has had nausea and on instance of vomiting before presentation.

 

PMH: Vitals:

 

HTN Temp: 98.8oF

 

Type II DM Wt: 202 lbs

 

Gout Ht: 5’8”

 

DVT – Caused by oral BCPs BP: 136/82

 

HR: 82 bpm

 

Current Medications: Notable Labs:

 

Lisinopril 10 mg daily WBC: 13,000/mm3

 

HCTZ 25 mg daily Total bilirubin: 0.8 mg/dL

 

Allopurinol 100 mg daily Direct bilirubin: 0.6 mg/dL

 

Multivitamin daily Alk Phos: 100 U/L

 

AST: 45 U/L

 

ALT: 30 U/L

 

Allergies:

 

Latex

Codeine

Amoxicillin

PE:

 

Eyes: EOMI

HENT: Normal

GI: Nondistended, minimal tenderness

Skin: Warm and dry

Neuro: Alert and Oriented

Psych: Appropriate mood

 

 

RESOURCES:

Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.

 

Chapter 64, “Drugs for Peptic Ulcer Disease” (pp. 589–597)

Chapter 65, “Laxatives” (pp. 598–604)

Chapter 66, “Other Gastrointestinal Drugs” (pp. 605–616)

Chapter 80, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 723–743)

 

 

 

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., . . . Sanya, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328–357. Retrieved from https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29367

 

 

 

This article details the diagnosis and management of nonalcoholic fatty liver disease. Review this article to gain an understanding of the underlying pathophysiology as well as the suggested pharmacotherapeutics that might be recommended to treat this disorder.

https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29367